Densitas announces a new collaboration partnership with TeleMammography Specialists of Decatur, Georgia. TeleMammography Specialists will be the first U.S. beta user for the new densitasquality™ solution from Densitas, which will be used to improve the communications and information sharing needed to meet EQUIP guidelines.
Densitas announces the signing of a new Alliance Partner Agreement with Blackford. This agreement gives Blackford the right to promote, market, sell, distribute, and license densitasdensity™ directly via integration with the Blackford PlatformTM. Work will now commence to integrate densitasdensity™ with the Blackford Platform.
HALIFAX, Nova Scotia, July 24, 2018 /PRNewswire/ -- Densitas, Inc., a breast imaging analytics innovator based in Halifax, Nova Scotia, announces a recently formalized partnership with the Leeds Teaching Hospitals NHS Trust in the UK.
Breast imaging analytics innovator Densitas Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its machine learning breast density assessment software.
The software empowers radiologists with standardized, personalized and automated density reports to optimize women’s breast health and follow-up care decisions.
Densitas Inc. announced today that it has received regulatory clearance for its automated breast density software, DM-Density. DM-Density has received regulatory clearance from the Australian Therapeutic Goods Administration (TGA) and will be available through the EnvoyAI Platform.
Researchers from the University of Manchester have published a review of breast density measurement methods in the journal Breast Cancer Research. The study clinically validates Densitas’ automated breast density measurement software as a practical solution for use in breast cancer risk models used to stratify patients based on their risk of breast cancer.
A study using a new, automated, area based percent breast density measurement algorithm to assess mammographic breast density, using “for demonstration” full field digital mammography (FFDM) images, was presented at the 2015 European Congress of Radiology (ECR) in Vienna (Austria). The new breast density measures could be used by researches for the development of personalized breast screening protocols.
Advanced breast imaging analytics provider, Densitas, today announced that it now offers its automated breast density software through EnvoyAI’s scalable distribution platform to facilitate streamlined deployment of its flagship product within hospital networks and clinics.
Densitas Inc., developer of advanced breast imaging analytics technologies, announced today that research is being presented at this year’s British Society of Breast Radiology (BSBR) scientific meeting that highlights the contribution the company’s automated breast density software, DM-Density, can make to clinical workflows.
Research Highlights Densitas Breast Density Software Processes Standard Digital Mammograms. Densitas Inc, developer of advanced breast imaging analytics technologies, announced today that research will be presented at the European Congress of Radiology (ECR) that highlights the company’s automated breast density software, DM-Density.
Radiologists use DM-Density when reviewing a woman's mammogram to assess breast density. Accurately assessing breast density is an important part of the mammography process, as dense breasts have a higher risk of developing breast cancer, and the dense breast tissue makes it challenging to differentiate it from cancer on the X-ray image.